IP Library Granted Patent US 11,395,887
Granted Patent B2
US 11,395,887 · App. 16/198,312 · Granted Jul 26, 2022

Intranasal device with inlet interface

Inventors: Craig Frederick Kohring (Seattle, WA); Christopher William Fuller (Seattle, WA)
Assignee: Impel Pharmaceuticals Inc.
A61M15/003A61M15/0035A61M15/08A61M15/009A61M2202/04A61M2202/064A61M2205/8225A61M2206/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,395,887
App. No.
16/198,312
Granted
Jul 26, 2022
Kind
B2
Abstract

A device for delivering a compound to the olfactory region of the nasal cavity includes an actuator body and a tip that removably couples to the actuator body. The actuator body includes a propellant channel in fluid communication with a propellant canister. The tip includes an exit channel, an inlet interface, one or more grooves, and an outlet orifice. The exit channel extends between a proximal end and a distal end of the tip. The inlet interface is positioned about a distal end of the exit channel, and the inlet interface couples to a compound container containing the compound. The grooves are positioned about the inlet interface and direct propellant from the propellant channel into the compound container, thereby agitating and entraining the compound in the compound container with the released propellant. The compound and the propellant then travel through the exit channel and out the outlet orifice.

Claims (20)

1. A device for delivering a compound to an upper nasal cavity comprising:

an actuator body comprising:

a propellant channel configured to be in fluid communication with a canister containing a propellant; and

a tip configured to removably couple to the actuator body, the tip comprising:

an outer wall and an inner wall, the inner wall forming an exit channel that extends between a proximal end and a distal end of the tip;

an inlet interface positioned about a distal end of the outer wall, the inlet interface configured to couple to a compound container containing the compound;

one or more grooves positioned about the inlet interface, such that, when the compound container is coupled to the inlet interface, a first portion of each groove is exposed within the propellant channel and a second portion of each groove is positioned within the compound container and wherein each groove is in fluid communication with the propellant channel and the exit channel; and

an outlet orifice disposed at a distal end of the exit channel, such that propellant released from the canister travels through the propellant channel and into the compound container via the one or more grooves, thereby contacting the compound and propelling the compound through the exit channel and out the outlet orifice.

2. The device of claim 1 , wherein the compound is a liquid or a powder.

3. The device of claim 1 , wherein the compound container is a capsule.

4. The device of claim 1 , wherein the inlet interface is a collar positioned at the proximal end of the tip, wherein the collar is configured to be inserted into the compound container.

5. The device of claim 1 , wherein the inlet interface comprises a puncture member that is configured to puncture the compound container.

6. The device of claim 5 , wherein the puncture member comprises one or more openings that are in fluid communication with the exit channel.

7. The device of claim 6 , wherein the one or more openings are positioned radially symmetric about the puncture member.

8. The device of claim 5 , wherein an inline force provided to the tip by a user is configured to translate the tip relative to the actuator body such that the puncture member punctures the compound container.

9. The device of claim 1 , wherein the tip is configured to be removably coupled from the actuator body for coupling the compound container to the inlet interface.

10. The device of claim 1 , further comprising a nozzle congruent with the exit channel.

11. The device of claim 1 , wherein the compound container is configured to couple to the inlet interface with an interference fit.

12. The device of claim 1 , wherein the one or more grooves are configured to direct propellant released from the canister into the compound container in an orthogonal direction relative to a bottom surface of the compound container.

13. The device of claim 1 , further comprising the compound container, wherein the compound container is pre-filled with the compound.

Assignments (11)
SECURITY INTEREST Recorded Jun 5, 2025
From: WOODWARD SPECIALTY LLC
To: ALTER DOMUS (US) LLC
Reel/Frame 071324/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2024
From: JN BIDCO LLC
To: WOODWARD SPECIALTY LLC
Reel/Frame 067062/0344 →
SECURITY INTEREST Recorded Mar 20, 2024
From: JN BIDCO LLC
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 066837/0144 →
RELEASE OF SECURITY INTEREST Recorded Feb 28, 2024
From: OAKTREE FUND ADMINISTRATION, LLC
To: IMPEL PHARMACEUTICALS, INC.
Reel/Frame 066699/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2024
From: IMPEL PHARMACEUTICALS INC.
To: JN BIDCO LLC
Reel/Frame 066601/0479 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF APPLICATION NUMBERS 12866448 AND APLICATION NUMBER 14292481 PREVIOUSLY RECORDED AT REEL: 059790 FRAME: 0722. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 4, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059855/0252 →
CHANGE OF NAME Recorded Apr 25, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059790/0722 →
SECURITY INTEREST Recorded Mar 17, 2022
From: IMPEL NEUROPHARMA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059300/0390 →
RELEASE OF SECURITY INTEREST Recorded Jul 6, 2021
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 056758/0495 →
SECURITY INTEREST Recorded Nov 5, 2020
From: IMPEL NEUROPHARMA, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 054287/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2019
From: KOHRING, CRAIG FREDERICK; FULLER, CHRISTOPHER WILLIAM
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 048775/0370 →
Continuity (2)
Provisional Application 62589326 · Nov 21, 2017
Related Publication 20190151576A1 · May 23, 2019